Easton Capital

Easton Capital

Pulse 2.0

bluebird bio (BLUE) Stock Price: Why It Surged Over 70% Today

Pulse 2.0

bluebird bio (BLUE) Stock Price: Why It Increased 21.14%

Pulse 2.0

bluebird bio (BLUE) Stock: $10 Price Target And Neutral Rating

$45,000,000 Venture capital (Series D)
FinSMEs

TigerConnect Closes $45M Series D Funding

$100,000,000 Venture capital
FinSMEs

Within3 Raises Over $100M in Growth Funding

TechCrunch

Ohio-based collaboration service for biotech and pharma research, Within3, raises $100 million

MedCity News

bluebird bio's stock tanks after report of serious toxicity in sickle cell patient

GeekWire

Providence St. Joseph Health family health app Circle acquired by Wildflower Health

Health
socalTECH.com

TigerText Becomes TigerConnect

$8,000,000 Venture capital (Series C)
FinSMEs

Wildflower Health Receives $8M in Funding

Funding Health
$250,000,000 Post-IPO equity
Twitter

Boston Business on Twitter

The Motley Fool

Better Buy: Agenus Inc. vs. bluebird bio

The Motley Fool

Why Global Blood Therapeutics Inc. Skyrocketed and bluebird bio Inc. Sank Today

The Motley Fool

Better Buy: bluebird bio vs. Inovio Pharmaceuticals

The Motley Fool

Better Buy: Juno Therapeutics vs. bluebird bio

The Motley Fool

bluebird bio Inc: Catnapping in Cambridge

The Motley Fool

Forget Bluebird Bio, Inc.: These 3 Stocks Are Better Buys

The Motley Fool

bluebird bio, Inc. Takes Flight Towards First Approval

The Motley Fool

Here's Why bluebird bio.'s Stock Tumbled in March

The Motley Fool

Why bluebird bio's Stock Jumped 12.9% on Wednesday